首页> 美国卫生研究院文献>Current Cardiology Reviews >What’s Old is New Again – A Review of the Current Evidence of Colchicine in Cardiovascular Medicine
【2h】

What’s Old is New Again – A Review of the Current Evidence of Colchicine in Cardiovascular Medicine

机译:旧的又是新的-心血管医学中秋水仙碱的最新研究回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Colchicine is a well-established drug approved by the Food and Drug Administration (FDA) for the prevention and treatment of gout. It possesses unique anti-inflammatory properties. Interests in the usage of colchicine in cardiovascular medicine have been rekindled recently with several large trials been carried out to investigate its efficacy in treatment of various cardiac conditions including pericarditis, postpericardiotomy syndrome, atrial fibrillation and coronary artery disease. In this review, the basic pharmacological properties of colchicine will be discussed, and the evidences of its benefits for different applications in cardiovascular medicine will be reviewed.
机译:秋水仙碱是经食品和药物管理局(FDA)批准用于预防和治疗痛风的成熟药物。它具有独特的抗炎特性。最近,对秋水仙碱在心血管医学中的用途的兴趣重新燃起,并进行了数项大型试验,以研究其在各种心脏疾病(包括心包炎,心包切开术后综合征,心房纤颤和冠状动脉疾病)的治疗中的功效。在这篇综述中,将讨论秋水仙碱的基本药理特性,并将综述其在心血管医学中不同应用的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号